You are here: Industry Insights > china

News List

Stainwei Granted Patent for anti-VEGF Monoclonal Antibody and its anti-PD-1 mAb americanpharmaceuticalreview
May 04, 2017
Stainwei Biotech announced it received a patent certificate (Patent No. US9,580,498) issued by the United States Patent and Trademark Office for its novel humanized anti-VEGF monoclonal antibody (mAb code name: hPV19).
WuXi NextCODE closes a $75 million Series B financing biospectrumasia
May 03, 2017
WuXi NextCODE, the contract genomics organization (CGO) building the global standard platform for genomic data, has closed a $75 million Series B financing from the company's existing investors and partners.
NeuroVive in partnership with Yungjin Pharm Corporation Ltd biospectrumasia
May 03, 2017
NeuroVive Pharmaceutical AB and Yungjin Pharm Corporation Ltd jointly announced that they have entered into a global licensing agreement on Yungjin Pharm's compound KL1333 for genetic mitochondrial disorders.
Yisheng Biopharma Starts Enrollment in Phase 1 Immuno-Oncology Clinical Trial of YS-ON-001 in Patien en-cphi.cn
May 02, 2017
Yisheng Biopharma Co., Ltd. ("Yisheng Biopharma"), a biopharmaceutical company focusing on research, development, manufacturing, sales and marketing of immuno-oncology products and vaccines...
China FDA approves country’s first all-oral regimen for chronic hepatitis C, Daklinza in combination cphi-online
May 02, 2017
Daklinza and Sunvepra combination approved for genotype 1b, the most common chronic hepatitis C (HCV) genotype in China; combination has a 91-99% cure rate.
Dragonfly Therapeutics Appoints Head of Biologics contractpharma
May 02, 2017
Grinberg brings track record of scientific accomplishments and creativity in protein-based drug development
Deloitte: Multinational Pharmaceutical Enterprises are in Deep Waters in China en-cphi.cn
April 28, 2017
Deloitte has recently issued a report New Healthcare Reform in a New Era--Challenges for Multinational Pharmaceutical Companies and Corresponding Countermeasures to be taken to analyze the 5 challenges of multinational pharmaceutical companies in China.
Sanner passes 60 million euro mark cphi-online
April 26, 2017
Significant investments in Bensheim headquarters; consistent portfolio additions; cleanroom expansion in China.
Oxford Cancer Biomarkers licenses rights to China for three colorectal cancer tests biospectrumasia
April 25, 2017
Oxford Cancer Biomarkers (OCB) said it will expand the use of three of its in vitro diagnostic tests for colorectal cancer into China through a partnership with MBM.
HITGEN announces drug discovery collaboration with The Scripps Research Institute and the California en-cphi.cn
April 24, 2017
HitGen Ltd. announced today a collaboration with The Scripps Research Institute (TSRI) and its affiliate, the California Institute for Biomedical Research (Calibr).

Previous page 1 2 3 4 5 6 7 8 9 10 ... 38 39 Next page